Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment

This study is currently recruiting participants.

Verified by Asociación para Evitar la Ceguera en México, November 2007

Sponsored by:	Asociación para Evitar la Ceguera en México
Information provided by:	Asociación para Evitar la Ceguera en México
ClinicalTrials.gov Identifier:	NCT00404209

Purpose

To investigate the feasibility and advantages of using pressurized perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting 23 GA vitrectomy using a dual, dynamic drive (3D)technology, in complicated retinal detachment surgeries.

Condition	Intervention	Phase
Retinal Detachment	Procedure: Vitrectomy	Phase III

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title:	Pressurized Perfluorocarbon Perfused 23 GA Vitrectomy in Complicated Diabetic Retinal Detachment

Further study details as provided by Asociación para Evitar la Ceguera en México:

Primary Outcome Measures:

Perfluorocarbon liquids consumption [ Time Frame: two months ] [ Designated as safety issue: No ]

Estimated Enrollment:	10
Study Start Date:	March 2007
Estimated Study Completion Date:	February 2008

Intervention Details:

pressurized 23GA vitrectomy with a 3D system

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Complicated retinal detachment with no more than 6months of evolution

Exclusion Criteria:

Retinal detachments of more than 6 months of evolution No light perception

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00404209

Contacts

Contact: Hugo Quiroz-Mercado, MD

5255 10841400 ext 1171

retinamex@yahoo.com

Locations

Mexico, Mexico DF
Asociación para Evitar la Ceguera en México, Hospital "Luis Sánchez Bulnes"	Recruiting
Mexico City, Mexico DF, Mexico, 04030
Contact: Hugo Quiroz-Mercado, MD 5255 10841400 ext 1171 retinamex@yahoo.com
Sub-Investigator: Maria A Martinez-Castellanos, MD
Sub-Investigator: Gerardo Garcia-Aguirre, MD
Sub-Investigator: Orlando Ustariz-Gonzalez, MD
Sub-Investigator: Jose L Guerrero-Naranjo, MD
Sub-Investigator: Jans Fromow-Guerra, MD

Sponsors and Collaborators

Asociación para Evitar la Ceguera en México

Investigators

Principal Investigator:	Hugo Quiroz-Mercado, MD	Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes"
Principal Investigator:	Raul Velez-Montoya, MD	Asociacion para Evitar la Ceguera en Mexico

More Information

Responsible Party:	Asociacion para evitar la ceguera en Mexico ( Hugo Quiroz-Mercado )
Study ID Numbers:	APEC-008
Study First Received:	June 30, 2006
Last Updated:	November 29, 2007
ClinicalTrials.gov Identifier:	NCT00404209
Health Authority:	Mexico: Ministry of Health

Study placed in the following topic categories:

Retinal Detachment
Eye Diseases
Retinal Diseases

ClinicalTrials.gov processed this record on January 14, 2009